Differentiation therapy of cancer. Potential advantages over conventional therapeutic approaches targeting death of cancer/tumor cells [8]

Medical Hypotheses

Volumn 65, Issue 6, 2005, Pages 1202-1203

  Cao, Tong ^a   Boon, Chin Heng ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER THERAPY; CELL DEATH; CELL PROLIFERATION; DIFFERENTIATION THERAPY; GAMMA IRRADIATION; HUMAN; LETTER; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SIDE EFFECT; STEM CELL; THEORETICAL STUDY; TOXICITY; TUMOR CELL;

ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; DRUG DELIVERY SYSTEMS; HUMANS; NEOPLASMS; RADIOTHERAPY;

EID: 26444439975     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.06.011     Document Type: Letter

References (5)

1. V. Guillemard, and H.U. Saragovi Novel approaches for targeted cancer therapy Curr Cancer Drug Targets 4 4 2004 313 326
2. A. Konski, S. Feigenberg, and E. Chow Palliative radiation therapy Semin Oncol 32 2 2005 156 164
3. S. Sell Stem cell origin of cancer and differentiation therapy Crit Rev Oncol Hematol 51 1 2004 1 28
4. S. Sell, and G.B. Pierce Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers Lab Invest 70 1 1994 6 22
5. D.R. Bell, and G. Van Zant Stem cells, aging, and cancer: inevitabilities and outcomes Oncogene 23 43 2004 7290 7296